AKT1 and breast carcinoma: Accordingly, in this study, we investigated the response of different types of breast-cancer cell lines to a combination of conventional chemotherapy [24] and synthetic lethality-based therapy [25] supplemented with Akt inhibition to prevent undesired cytoprotective effects of the latter [26].